A ticketed talk in Bergen County on eating, moving and keeping muscle while on a GLP-1. Event promotion with little news in it.
Recap by typeshit. Post by @heidiskolnik on Instagram.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
Lilly's 80-week phase 3 study of 1,152 adults, published in The Lancet, also showed HbA1c drops. Diarrhea and nausea were more common than on placebo.
Retatrutide is still in clinical trials, but PharmaVoice reports Lilly is already going after a network of illicit sellers offering it online.
Loading…